Dona Mathews highlights a new study showing a doubled risk of depression after a medical diagnosis - especially in the first ...

Results from a small study suggest ketamine’s antidepressant effects may require activation of the brain’s opioid system.

AUVELITYⓇ (“dextromethorphan HBr and bupropion HCl; 45 / 105 mg”) is a prescription oral medicine used to treat adults with major depressive disorder (MDD).

Dr. Jayesh Kamath, psychiatrist with UConn Health, explains what Major Depressive Disorder and how it can impact patients.

The Food and Drug Administration (FDA) has cleared Magstim’s Horizon 3.0 Transcranial Magnetic Stimulation (TMS) Therapy System as an adjunctive nonpharmacological therapy for major depressive ...

It is also for major depressive disorder with acute suicidal ideation or behavior, meaning depression with an immediate or very short-term risk of acting on suicidal thoughts or plans.

Topline data were announced from a phase 3 trial evaluating navacaprant for the treatment of major depressive disorder (MDD). Navacaprant is a highly selective kappa opioid receptor (KOR ...

The study enrolled 301 patients with major depressive disorder, or MDD, defined by an objective biomarker that was assessed before randomization. This biomarker is low levels of BDNF, a brain ...

Promising new way to modulate brain cell activity to potentially treat major depressive disorder in adults Date: May 21, 2025 Source: The Mount Sinai Hospital / Mount Sinai School of Medicine ...